First Circuit Court Blocks HHS Request to Restart 340B Rebate Pilot

Yesterday, the U.S. Court of Appeals for the First Circuit declined to stay a lower court’s injunction blocking the 340B Rebate Model Pilot Program, meaning the pilot remains on hold while the legal appeals proceed. The court’s decision leaves in place the December 29 order in which the federal district judge prevented HHS from launching the pilot on January 1, finding that the agency likely failed to adequately consider the longstanding reliance interests and operational realities of 340B covered entities. The government had asked the appeals court for an emergency pause of that injunction, but the court declined, signaling skepticism about the government’s likelihood of success on appeal. 


Why This Matters:

The court’s decision keeps 340B upfront drug discounts in place for now, protecting entities from cash-flow strain and administrative burdens while the legal challenge to the 340B pilot continues.


340B Performance 360 Streamline All Your 340B Data

Seamless Data. Smarter Decisions. Stronger Performance


In practical terms, this means entities participating in 340B can continue receiving discounted drug prices up front, instead of purchasing at WAC and waiting for rebates to receive the statutory discount. The courts have been concerned that the rebate pilot would shift financial risk and administrative burden onto safety-net providers, straining cash flow and resources needed to serve patients, without sufficient justification or planning by the government. By keeping the pilot on hold, the appeals court preserved the status quo while it considers the case on the merits, a development widely viewed as significant for covered entities that have depended on upfront 340B savings throughout the program’s decades of operations.


Ready for expert guidance and support for optimizing your 340B program based on the latest industry events? Contact us today to learn how we can support your entity's success.


Previous
Previous

340B Rebate Pilot Update – Legal Action Paused, Future Uncertain

Next
Next

HRSA Posts Announcement that the 340B Rebate Pilot Implementation is Paused